Home › NDC Lookup › RxCUI directory › RxCUI 727705

0.8 ML adalimumab 50 MG/ML Prefilled Syringe [Humira] — RxCUI 727705

Name: 0.8 ML adalimumab 50 MG/ML Prefilled Syringe [Humira] (RxCUI 727705)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 727705 Semantic branded drug · SBD ● Current RxNorm concept 9 FDA products 17 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI727705

Official name0.8 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known as0.8 ML Humira 50 MG/ML Prefilled Syringe; Humira 40 MG in 0.8 ML Prefilled Syringe; Humira 40 MG per 0.8 ML Prefilled Syringe

FDA products mapped9

Package NDCs mapped17

Reported Medicaid activity (SDUD)380,296 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Adalimumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Adalimumab is approved for quite a few inflammatory conditions — rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psor...
What conditions is adalimumab actually approved to treat?
You'll use either an autoinjector pen or a prefilled syringe, depending on what your doctor prescribes. Before injecting, take it out of the refrigerator and let it sit for 15 to 3...
How do I give myself this injection at home?

📖 Read our full Adalimumab Injection guide →

🕸️ Concept Web — How 0.8 ML adalimumab 50 MG/ML Prefilled Syringe [Hu... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 0.8 ML adalimumab 50 MG/ML Prefilled Syringe [Humira] RxCUI 727705 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Adalimumab 327361 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Humira 353484 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Adalimumab Prefilled Syringe 727702 SCDF
- Adalimumab Injectable Product 1163691 SCDG
- Adalimumab Prefilled Syringe [Humira] 727704 SBDF
- Humira Injectable Product 1171992 SBDG
- Prefilled Syringe 721656 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- 0.8 ML adalimumab 50 MG/ML Prefilled Syringe 727703 SCD
- Adalimumab 50 MG/ML 358817 SCDC
- Adalimumab 50 MG/ML [Humira] 576023 SBDC
Packs 4

Fixed collections of drugs packaged and sold together, like dose packs.
- {3 (0.8 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]) } Pack [Humira Pediatric Crohn's Disease Starter Package (3 count)] 1594358 BPCK
- {6 (0.8 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]) } Pack [Humira Pediatric Crohn's Disease Starter Package (6 count)] 1594352 BPCK
- {3 (0.8 ML adalimumab 50 MG/ML Prefilled Syringe) } Pack 1594357 GPCK
- {6 (0.8 ML adalimumab 50 MG/ML Prefilled Syringe) } Pack 825169 GPCK

Showing up to 8 concepts per family — 15 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

0.8 ML adalimumab 50 MG/ML Prefilled Syringe SCD · 727703
{3 (0.8 ML adalimumab 50 MG/ML Prefilled Syringe) } Pack GPCK · 1594357
{6 (0.8 ML adalimumab 50 MG/ML Prefilled Syringe) } Pack GPCK · 825169
Adalimumab 50 MG/ML SCDC · 358817
Adalimumab Prefilled Syringe SCDF · 727702
Adalimumab Injectable Product SCDG · 1163691

Brand-Name Concepts

{3 (0.8 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]) } Pack [Humira Pediatric Crohn's Disease Starter Package (3 count)] BPCK · 1594358
{6 (0.8 ML adalimumab 50 MG/ML Prefilled Syringe [Humira]) } Pack [Humira Pediatric Crohn's Disease Starter Package (6 count)] BPCK · 1594352
Adalimumab 50 MG/ML [Humira] SBDC · 576023
Adalimumab Prefilled Syringe [Humira] SBDF · 727704
Humira Injectable Product SBDG · 1171992
Humira BN · 353484

📦 FDA Products & Package NDCs

9 products · 17 package NDCs

17 package NDCs map to RxCUI 727705 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00074-0124-01	1 KIT in 1 CARTON (0074-0124-01) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2017-04-21
00074-0124-02	2 KIT in 1 CARTON (0074-0124-02) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2020-12-16
00074-0124-03	3 KIT in 1 CARTON (0074-0124-03) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2017-04-21
00074-0124-04	4 KIT in 1 CARTON (0074-0124-04) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2021-02-24
00074-0124-74	1 KIT in 1 CARTON (0074-0124-74) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2017-04-21
00074-0243-02	2 KIT in 1 CARTON (0074-0243-02) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2015-11-23
00074-0554-01	1 KIT in 1 CARTON (0074-0554-01) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2016-03-09
00074-0554-02	2 KIT in 1 CARTON (0074-0554-02) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2016-03-09
00074-0554-71	2 KIT in 1 CARTON (0074-0554-71) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2016-03-09
00074-0554-74	1 KIT in 1 CARTON (0074-0554-74) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2016-03-09
00074-0616-02	2 KIT in 1 CARTON (0074-0616-02) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2017-04-28
00074-0616-71	2 KIT in 1 CARTON (0074-0616-71) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2017-04-28
00074-0817-02	2 KIT in 1 CARTON (0074-0817-02) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2017-04-28
00074-1539-03	3 KIT in 1 CARTON (0074-1539-03) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2017-04-21
00074-2540-01	1 KIT in 1 CARTON (0074-2540-01) / 1 KIT in 1 KIT * 1 mL i...	Humira	AbbVie Inc.	2016-10-17
00074-3799-02	2 KIT in 1 CARTON (0074-3799-02) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2002-12-31
00074-4339-02	2 KIT in 1 CARTON (0074-4339-02) / 1 KIT in 1 KIT * 1 SYRI...	Humira	AbbVie Inc.	2006-06-23

Observed labelers: AbbVie Inc. (17) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.